Hepatobiliary cancers : translational advances and molecular medicine /: translational advances and molecular medicine. (2022)

• Record Type: Book
• Further Information: Note: Volume editors, Alphonse C. Sirica, Paul B. Fisher.
• Editors: Sirica, Alphonse C; Fisher, Paul B
• Contents: 1. Liver Cancer Risk-Predictive Molecular Biomarkers Specific to Clinico-epidemiological Contexts; Yujin Hoshida, Naoto Kubota, Naoto Fujiwara; 2. Inflammatory Pathways and Hepatobiliary Cancer Risk Mechanisms and Prevention; Mario Strazzabosco and Massimiliamo Cadamuro; 3. Causes and Functional Intricacies of Inter- and Intratumor Heterogeneity in Primary Liver Cancers; Xin Wei Wang and Subreen Khatib; 4. Implication of Genetic Heterogeneity in Hepatocellular Cancer; Renumathy Dhanasekaran; 5. Understanding the Genetic Basis for Cholangiocarcinoma; Lewis R. Roberts and Mikayla A. Schmidt; 6. Novel Insights into Molecular and Immune Subtypes of Intrahepatic Cholangiocarcinoma; Daniela Sia and Emily Bramel; 7. Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma Progression and Therapeutic Resistance; Silvia Affo, Aashreya Ravichandra, Sonakshi Bhattacharjee; 8. Mechanisms and Clinical Significance of TGF-ß in Hepatobiliary Cancer Progression; Lopa Mishra and Zobia Zaidi; 9. Matricellular proteins in intrahepatic cholangiocarcinoma; Alphonse Eugene Sirica; 10. Yap Activation and Hippo Pathway Signaling in the Pathogenesis and Prognosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma; Satdarshan (Paul) Singh Monga, Sungjin Ko, Yuhua Xue, George K. Michalopoulos; 11. Patient-derived Functional Organoids as a Personalized Approach for Drug Screening Against Hepatobiliary Cancers; Florin M. Selaru and Ling Li; 12. Molecular Therapeutic Targets for Cholangiocarcinoma: Present Challenges and Future Possibilities; Jesper B. Andersen, Colm J. O’Rourke, Dan Høgdall; 13. Immunotherapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Current and Developing Strategies; Bruno Sangro and Josepmaria Argemi; 14. Immunotherapy for Hepatobiliary Cancers: Emerging Targets and Translational Advances; Mitchell Ho, Dan Li, Shaoli Lin, Jessica Hong
• Publisher Details: Amsterdam : Academic Press
• Publication Date: 2022
• Extent: 1 online resource
• Subjects: 616.99436; Liver -- Cancer; Liver -- Cancer -- Treatment
• Languages: English
• ISBNs: 9780323983938
• Related ISBNs: 9780323983921
• Notes: Note: Description based on CIP data; resource not viewed.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.